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Abstract
Background: Most of the known functions of microglia, including neurotoxic and neuroprotective properties, are
attributed to morphologically-activated microglia. Resting, ramified microglia are suggested to primarily monitor
their environment including synapses. Here, we show an active protective role of ramified microglia in
excitotoxicity-induced neurodegeneration.
Methods: Mouse organotypic hippocampal slice cultures were treated with N-methyl-D-aspartic acid (NMDA) to
induce excitotoxic neuronal cell death. This procedure was performed in slices containing resting microglia or
slices that were chemically or genetically depleted of their endogenous microglia.
Results: Treatment of mouse organotypic hippocampal slice cultures with 10-50 μM N-methyl-D-aspartic acid
(NMDA) induced region-specific excitotoxic neuronal cell death with CA1 neurons being most vulnerable, whereas
CA3 and DG neurons were affected less. Ablation of ramified microglia severely enhanced NMDA-induced neuronal
cell death in the CA3 and DG region rendering them almost as sensitive as CA1 neurons. Replenishment of
microglia-free slices with microglia restored the original resistance of CA3 and DG neurons towards NMDA.
Conclusions: Our data strongly suggest that ramified microglia not only screen their microenvironment but
additionally protect hippocampal neurons under pathological conditions. Morphological activation of ramified
microglia is thus not required to influence neuronal survival.
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Background
Brain tissue is highly sensitive to injury because of its
restricted regenerative capacity. From the outside, the
brain is protected by the skull and the blood-brain bar-
rier [1]. Within the central nervous system (CNS),
microglia are the first line of defense that respond
rapidly to any type of brain injury [2-5]. This microglia
response has long been defined as microglia activation
and based on morphological findings, microglia activa-
tion was originally described as a stereotypic and graded
p r o c e s s[ 2 , 5 ] .T h i sv i e wo fm i c r o g l i af u n c t i o nh a sb e e n
challenged in the last years [4]. Various studies using
two-photon microscopy have shown that ramified
microglia are not “resting”, as it has long been thought,
but instead are very motile cells that constantly move
their processes [6-8]. Microglia constantly screen their
microenvironment, making them the sentinels of the
CNS. Microglia are thus active already under healthy
conditions but change their morphology and function in
response to a given stimulus, for example neuronal
stress signals. They first direct their processes towards
the injury before they retract their processes and
become motile cells that migrate to the site of injury
[6-8]. The microglia response to injury can also be
accompanied by proliferation [9,10].
It is now clear that microglia react with a variety of
different reactions by integrating multifarious inputs
[4,11,12]. In line with this, microglia responses are not
inevitably neurotoxic as it has long been thought. Var-
ious neuroprotective effects of microglia have been
demonstrated recently in vivo. Microglia were found
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toxicity [13] and in stroke [14]. Moreover, protective
microglia activity was described in mouse models of
amyotrophic lateral sclerosis [15] and Alzheimer’sd i s -
ease [16]. However, microglial neurotoxicity can occur
in case of overshooting and uncontrolled stimulation of
microglia [3,17] or when microglia function is impaired
[15,18,19]. Proper facilitation of microglia function is
therefore of crucial importance for the survival of neu-
rons under pathological conditions.
It is important to note that the studies mentioned
above all focus on the functions of morphologically acti-
vated (non-ramified) microglia. Although both neuro-
protective- and neurodegenerative properties have been
attributed to these ‘activated’ microglia, little is known
about the properties or functions of ‘screening’ ramified
microglia. The more recent findings that ramified
microglia contact active synapses [20,21], suggests a
cell-cell interaction between ramified microglia and neu-
rons, which however, is not yet understood.
In order to study the role of ramified microglia, we made
u s eo fam o u s eo r g a n o t y p i ch i p p o c a m p a ls l i c ec u l t u r e
model in which microglia maintain their ramified mor-
phology comparable to the in vivo situation. Since micro-
glia can be specifically eliminated from these slice cultures
[22] without affecting other cell types [23-25], this model
provides an ideal system to analyze the function of micro-
glia in their ramified state. Here, we provide evidence that
the presence of ramified microglia is essential for the sur-
vival of dentate gyrus (DG) and CA3 neurons in N-
methyl-D-aspartic acid (NMDA)-induced excitotoxicity,
strongly indicating that ramified microglia, next to their
monitoring function display neuroprotective properties.
Methods
Animals
All experiments have been approved by the Dutch ani-
mal experimental committee. The C57BL/6 J mice (Har-
lan) were housed and handled in accordance with the
guidelines of the central animal laboratory facility of
Groningen and the local central animal facility of the
Medical Faculty (Freiburg). CD11b-HSVTK mice were
housed at the animal housing facility FEM Charité-Uni-
versitätsmedizin Berlin, in Berlin and were handled
according to the guidelines of the local animal use and
care authorities (LAGESO Berlin).
Chemicals
Culture media and supplements were all obtained from
GIBCO (Invitrogen, The Netherlands), unless mentioned
otherwise. Multi-lamellar CL2MDP (clodronate)-liposomes
(Lip-CL) were obtained from the Department of Molecu-
lar Cell Biology of the Free University of Amsterdam, The
Netherlands (for an extensive preparation protocol see
[26]). Clodronate was a gift of Roche Diagnostics (Man-
nheim, Germany), phosphatidylcholine (Lipoid EPC) was
obtained from Lipoid (Ludwigshafen, Germany) and cho-
lesterol was purchased from Sigma (USA).
Preparation of organotypic hippocampal slice cultures
Organotypic hippocampal slice cultures were prepared
as described previously [27] with minor modifications.
In brief, slice cultures were prepared from 2 to 3 day
old mouse pups under sterile conditions. After decapita-
tion, the brains were removed and the hippocampi from
both hemispheres were acutely isolated in ice cold
serum-free Hank’s Balanced Salt Solution (HBSS), sup-
plemented with 0.5% glucose (Sigma) and 15 mM
HEPES. Isolated hippocampi were cut into 350-375 μM
thick slices using a tissue chopper (McIlwain) and were
transferred to 0.4 μM culture plate inserts (Millipore,
PICM03050). These culture plate inserts, containing
four to six slices, were placed in six-well plates contain-
ing 1.2 ml of culture medium per well. Culture medium
(pH 7.2) consisted of 0.5× minimum essential medium
(MEM) containing 25% heat-inactivated horse serum,
25% BME basal medium without glutamate, 2 mM glu-
tamax and 0.65% glucose. The slice cultures were kept
at 35°C in a humidified atmosphere (5% CO2)a n dt h e
culture medium was refreshed the first day after pre-
paration and every consecutive 2 days.
Depletion of microglia from slice cultures
We used two methods to specifically deplete microglia
from freshly prepared slice cultures without affecting
other cell-types. In the first method, slice cultures were
placed on culture plate inserts and incubated with
approximately 0.5 mg/ml Lip-CL solution (1:10 lipo-
some dilution in standard slice culture medium) for 24
h at 35°C. Subsequently, the slice cultures were carefully
rinsed in PBS (35°C) to wash away residual liposomes
and placed on fresh culture medium. After depletion the
medium was refreshed every 2 days. Both vehicle-treated
slice cultures and slice cultures treated with empty lipo-
somes served as controls.
In the second method, slice cultures derived from
CD11b-HSVTK mice were treated with 5 μg/ml ganci-
clovir (GCV, Sigma) in standard slice culture medium
(until the end of the experiments) to specifically deplete
the microglia population. Also here the slice cultures
were kept at 35°C. GCV-treated slice cultures derived
from wild type littermates and non-treated slice cultures
derived from CD11b-HSVTK mice served as controls.
Replenishment of slice cultures with primary mouse
microglia
Mixed glial cell cultures from 1-day old C57BL/6 mice
were prepared and cultured as described elsewhere [28].
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flow cytometry) were harvested 14 days after prepara-
tion by shaking the culture flasks for 15 min at room
temperature at 100 rpm. The medium containing micro-
glia was transferred to a 50 ml tube and the cells were
pelleted by centrifugation at 300 × g for 10 min at room
temperature. Microglia were resuspended in slice culture
medium with a cell densitiy of 200 cells per μl. For
microglia replenishment experiments, 400 cells in a
volume of 2 μl were carefully pipetted onto 9-days old
slice cultures depleted of their endogenous microglia
population with the Lip-CL method. These slice cultures
were maintained for an additional 12 days prior to
induction of excitotoxicity.
Induction of excitotoxicity in slice cultures
Unless mentioned otherwise, slice cultures were placed
after 6 days in culture in slice culture medium contain-
ing various concentrations of the glutamate receptor-
agonist N-methyl-D-aspartic acid (NMDA, Sigma) for 4
h to induce excitotoxicity. Subsequently, the medium
was replaced with standard culture medium without
NMDA. NMDA-treated slice cultures were kept in cul-
ture for 24 h after the NMDA challenge. Vehicle-treated
slice cultures and slice cultures pre-treated with
NMDA-antagonist MK-801 (30 μM) served as controls.
Immunohistochemistry
For immunohistochemical analysis, control and NMDA-
challenged slice cultures were shortly rinsed in phos-
phate-buffered saline (PBS, 35°C) and fixated with 4%
paraformaldehyde overnight at 4°C. After fixation, the
slice cultures were rinsed in PBS and pre-incubated with
5% normal goat serum (NGS, Vector) in PBS containing
0.3% Triton X-100 (PBS
+) for at least 1 hour. Subse-
quently, the slice cultures were incubated with the
appropriate primary antibodies overnight in 1% NGS/
PBS
+ at 4°C. The following primary antibodies were
used: rabbit-anti-Iba1 (1:1000, Wako 019-19741) for
detection of microglia, mouse-anti-GFAP (1:600, Chemi-
con MAB3402) for detection of astrocytes and mouse-
anti-NeuN (1:1000, Chemicon MAB377) for detection of
neuronal nuclei. Secondary antibodies used were don-
key-anti-mouse-Alexa488 (Molecular Probes) for NeuN,
donkey-anti-rabbit-Alexa633 (Molecular Probes) for
Iba1 and goat-anti-mouse-Cy3 (Jackson IR Laboratories)
for GFAP. Analysis of the slice cultures was done by
confocal imaging using a Leica SP2 AOBS system (Leica
Microsystems).
Analysis of microglia morphology
To analyse the morphology of endogenous or primary
cultured mouse microglia replenished to slice cultures,
z-stacks of slice cultures were generated by confocal
microscopy using a ZEISS LSM 510 META UV inverted
microscope at 50× magnification (LD LCI Plan-Neofluar
25×/0.8 Imm. Korr. DIC, oil immersion, 2× digital
zoom). Microglia were visualized by Iba1 immunofluor-
escent staining.
The images were analyzed using IMARIS software
(Bitplane). Reconstructions of microglia filaments were
generared by the IMARIS tool filament tracer. Tracing
was performed in a region of interest using the auto-
matic detection mode, no loops allowed, start and end
points were calculated via spot detection. The para-
meters total dendritic length (sum of length of all den-
drites) and number of branch points were analyzed for
25 cells per group.
RNA isolation and quantitative PCR
Slice cultures (6 per condition) were lysed in RLT buffer
(Qiagen) and total RNA was isolated according to man-
ufacturers’ protocol. Total RNA was transcribed into
cDNA as described previously [29] and gene expression
for b-III-tubulin, GFAP, CD11b and the NMDA recep-
tor subunits NR1, NR2A and NR2B (see Table 1 for pri-
mers) were analyzed using the ABI Prism
® 7900 HT
real time PCR instrument and the iTAQTM SYBR
Green Supermix with ROX (Bio-Rad 172-5850). HMBS
(see Table 1 for primers) served as a reference gene for
normalization. Reactions were run in triplets and thresh-
old cycles were determined manually by setting thresh-
olds for fluorescence intensity. Relative gene expression
levels were analyzed by the 2-ΔΔCT method [30].
Quantification of neuronal cell death
To quantify neuronal cell death in response to NMDA-
induced excitotoxicity, slice cultures were incubated
Table 1 List of primers used for qPCR experiments
Gene Accession
number
Primer sequence
HMBS XM129404 Forward CCGAGCCAAGCACCAGGATA
Reverse CTCCTTCCAGGTGCCTCAGA
NMDA1 NM_008169 Forward TGGCCCTGTCAGTGTGTGAG
Reverse GGAGTGAAGTGGTCGTTGGG
NMDA2A NM_008170 Forward CGCGAACTTCGAAATCTGTG
Reverse AGGCTCTTAGGGTCAGTGCG
NMDA2B NM_008171 Forward ACCTGCATGCGGAATACAGTC
Reverse CAAAACCCCTTGCAGCATTT
GFAP NM_01277 Forward GTTTCATCTTGGAGCTTCTGC
Reverse GGAGGTGGAGAGGGACAAC
bIII-
tubulin
NM_023279 Forward TGTTCAAACGCATCTCGGAG
Reverse TCCATCTCATCCATGCCCTC
CD11b NM-1082960 Forward TACCGTCTACTACCCATCTGGC
Reverse TTGGTGAGCGGGTTCTGG
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after the NMDA-challenge [31,32]. Confocal images of
the neuronal layers were taken mid-section at 40× mag-
nification and the number of double positive cells
(NeuN/PI) were quantified using ImageJ software (as
described in [33]). The percentage of neuronal cell
death was determined by the number of double positive
cells (NeuN/PI) divided by the total number of NeuN-
positive cells per neuronal layer.
In the microglia replenishment experiments, cell death
in the neuronal layer of the dentate gyrus was deter-
mined by the total PI uptake (fluorescence intensity)
using ImageJ software. After acquisition of mid-section
confocal images, the dentate gyrus was defined as region
of interest (ROI) using the polygon selection tool.
NeuN- and PI-positivity was analyzed in the respective
channels using the measurement setting “area fraction”
in the ROI. Cell death was evaluated by calculation of
the PI-positive area fraction as the percentage of the
NeuN-positive area fraction.
Statistical analysis
Data are represented as the mean ± standard error of
the mean (SEM). For neuronal cell death quantification,
statistical comparison between groups was performed
using one-way analysis of variance (ANOVA) with Bon-
ferroni’s posthoc test and p-values smaller than 0.05
were considered significant. Student’s t-test was used for
qPCR analysis. All statistical tests were performed in
SPSS version 14.0.2 (IBM).
Results
NMDA-induced excitotoxicity in mouse organotypic
hippocampal slice cultures
To examine the effects of NMDA-induced excitotoxicity
on neuronal degeneration and microglial activation, we
used mouse organotypic hippocampal slice cultures
derived from C57BL/6 J mice. After six days in culture,
the neuronal layers CA1, CA3 and DG were well pre-
served under standard culture conditions and neuronal
cell death, as determined by NeuN/PI double positivity,
was minimal (< 1%; Figure 1A, B control). Treatment
with 10, 15, 25 and 50 μM NMDA induced a concentra-
tion-dependent and region-specific increase in neuronal
cell death in the slice cultures (Figure 1A, C). Highest
vulnerability towards NMDA was observed in the CA1
region with 67.1 ± 16.3% cell death at 10 μMN M D A .
At concentrations of 15-50 μM NMDA neuronal cell
death in the CA1 reached maximum levels (97.1 ± 1.1-
100%). In contrast, CA3 neurons were less susceptible
Figure 1 NMDA-induced neurodegeneration in mouse hippocampal slice cultures. After 6 days in culture, hippocampal slice cultures were
treated with concentrations of 0 (control), 10, 15, 25 and 50 μM NMDA. Treatment with NMDA clearly induced cell death in the slice cultures as
determined by propidium iodide uptake (PI; red), which co-localized with the neuronal nuclear marker NeuN (C, white arrow), indicating that
NMDA specifically induced neuronal cell death. A concentration-dependent vulnerability towards NMDA was observed as neurons of the CA1
region were most sensitive to the NMDA-treatment (with 67.1% cell death at 10 μM NMDA), followed by the CA3 (41.7% at 15 μM NMDA) and
finally the DG, which showed relatively low levels of cell death even at 50 μM NMDA (30.7%). Control slice cultures showed hardly any cell death
(< 1%, B). Treatment of slice cultures with the NMDA-antagonist MK-801 (30 μM) for 1 hour prior to NMDA-treatment completely blocked
NMDA-induced neuronal cell death. The percentages of neuronal cell death per neuronal cell layer (DG/CA3/CA1) were quantified and are
represented in figure 5. Scale bars indicate 100 μm( A) and 25 μm( B,C).
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μM NMDA (1.9 ± 0.8%) and pronounced cell death was
only detected at concentrations of 15 μM NMDA (41.7
± 11.3%), 25 μM NMDA (79.9 ± 8.6%) and 50 μM
NMDA (96.4 ± 1.5%). The DG region was least sensitive
to NMDA with 6.5 ± 2% cell death at 10 μMN M D A ,
12.7 ± 1% at 15 μM NMDA, 23.5 ± 2.1% at 25 μM
NMDA and 30.7 ± 4.1% at 50 μM NMDA. NMDA con-
centrations lower than 10 μM did not induce significant
cell death in any of the neuronal regions (data not
shown). Pre-treatment for 1 hour with the NMDA
antagonist MK-801 prior to NMDA treatment comple-
tely inhibited NMDA-induced neuronal cell death (Fig-
ure 1A) in all regions and percentages of neuronal cell
death were equal to control conditions (DG: 2.3 ± 1%;
CA3: 4.0 ± 0.5; CA1: 1.4 ± 0.6%).
Changes in microglial morphology in response to
excitotoxicity coincides with selective neuronal
vulnerability towards NMDA
Next, we determined the effects of NMDA-induced
excitotoxicity on microglial morphology. After 6 days in
culture, microglia were evenly distributed throughout
the slice culture (Figure 2A) and showed typical ramified
morphology with small somata and long processes with
secondary and tertiary branches (Figure 2B-D). Treat-
ment of slice cultures with toxic concentrations of
NMDA caused changes in microglia morphology that
were dependent on the region (Figure 2E-L). Treatment
with 10 μM NMDA induced an accumulation of mor-
phologically activated microglia in the CA1 region (Fig-
ure 2E, arrow) with rounded morphology and retraction
of dendrites (Figure 2F). In contrast, in the CA3 region
(Figure 2G) and the DG region (Figure 2H) changes in
microglia morphology were not detected and microglia
remained in their ramified state as seen in control slice
cultures. In response to treatment with 15 μMN M D A
(Figure 2I) round microglia were observed in both the
CA1 region (Figure 2J) and the CA3 region (Figure 2K).
The morphological response of microglia in the DG
region however was minimal in response to 15 μM
NMDA, only few microglia displayed a so-called “hyper-
trophic” morphology with slightly thickened and shor-
tened dendrites (Figure 2L). Treatment with 25 μM
NMDA and 50 μM NMDA resulted in pronounced
accumulation of morphologically activated microglia in
all three neuronal regions (data not shown).
Depletion of microglia from slice cultures using liposome-
encapsulated clodronate
Since there is little evidence for NMDA-receptor expres-
sion in microglia, a direct effect of NDMA in these cells
that would stimulate them to kill neurons is not very
likely. However, the tight correlation between neuronal
death and morphological microglia activation has often
led to the concept that these cells have neurotoxic prop-
erties. We therefore depleted microglia from mouse slice
cultures using liposome-encapsulated clodronate (Lip-
CL) to study the role of these cells in NMDA-induced
excitotoxicity. Lip-CL has been shown to successfully
deplete microglia from mouse organotypic slice cultures,
without affecting other cell-types [23,24]. Overnight
treatment with 0.5 mg/ml Lip-CL directly after slice cul-
ture preparation and subsequent culturing in standard
culture medium for 6 days reduced the microglia popu-
lation to less than 5% (Figure 3A and 3D). In line with
previous findings, both astrocytes (Figure 3E) and neu-
rons (Figure 3F) were not affected by the Lip-CL treat-
ment and the number and morphology of these cells did
not differ from those in untreated controls (Figure 3B-
C). Additional mRNA expression analysis corroborated
these findings, since the ablation of microglia did not
influence the mRNA levels of GFAP (astrocyte marker)
and b-3-tubulin (neuronal marker) (Figure 3G). As posi-
tive control for the depletion we determined the expres-
sion levels of the microglia marker CD11b, which
dropped to almost undetectable levels in microglia
depleted slices (Figure 3G). The mRNA expression levels
of the 3 NMDA receptor subunits NR1, NR2A and
NR2B were not affected by Lip-CL treatment (Figure
3G), indicating that microglia ablation did not have a
direct effect on neuronal NMDA receptor expression,
which is confirmed by control experiments showing that
MK-801 completely blocked all NMDA effects irrespec-
tive of the presence of microglia in the slice (Additional
file 1: Figure S1). Moreover, treatment with liposomes
without clodronate (Lip-PBS) did not result in microglia
depletion or neuronal cell death (data not shown).
Depletion of microglia results in severe neuronal loss in
response to excitotoxicity
To determine the role of microglia in excitotoxicity,
control and microglia-depleted slice cultures were trea-
ted with 0-50 μM NMDA (Figure 4). Already at a low
concentration of NMDA (10 μM )as e v e r ei n c r e a s ei n
neuronal cell death was observed in microglia-depleted
slice cultures, when compared to control conditions
(Figure 4A-C). Especially in the DG region (Figure 4A)
neuronal cell death was strongly enhanced in absence of
microglia with 30.9 ± 5.1% cell death at 10 μMN M D A
(compared to 6.5 ± 2% in controls), 66.0 ± 4.8% at 15
μM NMDA (compared to 12.7 ± 1% in controls), 74.7 ±
2.5% at 25 μM NMDA (compared to 23.5 ± 2.1% in
controls) and 89.4 ± 4.5% at 50 μM NMDA (compared
to 30.7 ± 4.1% in controls). Neuronal cell death in the
CA3 region (Figure 4B) was also significantly enhanced
in microglia-depleted slice cultures in response to 10
μM NMDA (33.0 ± 8.8% compared to 1.9 ± 0.8% in
Vinet et al. Journal of Neuroinflammation 2012, 9:27
http://www.jneuroinflammation.com/content/9/1/27
Page 5 of 15Figure 2 Microglial activation coincides with selective neuronal vulnerability towards excitotoxicity. Confocal images of microglia in
control (A-D), 10 μM( E-H) and 15 μM( I-L) NMDA-treated slice cultures, as determined by Iba1-immuno-histochemistry. After 6 days in culture
(A), microglia were evenly distributed throughout the slice cultures and displayed a typical ramified morphology (B:CA1, C:CA3, D:DG). At 10 μM
NMDA (E), changes in the CA1 region were clearly visible as numerous microglia accumulated at the site of injury (E, arrow). Morphologically,
these microglia displayed an “activated” phenotype (F, CA1) with enlarged somata and loss of secondary and tertiary branching. In contrast,
accumulation of microglia did not occur in the CA3 (G) and DG (H) and these cells retained their ramified phenotype. At 15 μM NMDA,
pronounced accumulation of morphologically activated microglia (I, arrows) was observed in both CA1 (J) and CA3 (K). In contrast, microglia in
the DG (L) showed only mild activation and accumulation of microglia was minimal in this region. Scale bars indicate 300 μM (overviews) and
25 μM (magnifications). Confocal images were gray-scaled and inversed.
Vinet et al. Journal of Neuroinflammation 2012, 9:27
http://www.jneuroinflammation.com/content/9/1/27
Page 6 of 15Figure 3 Liposomic clodronate specifically depletes microglia from hippocampal slice cultures.U n t r e a t e dm o u s eh i p p o c a m p a ls l i c e
cultures showed preserved organotypic structure with ramified microglia (A, Iba1), astrocytes (B, GFAP) and neuronal layers CA1/CA3/DG (C,
Neun). Overnight treatment with liposome-encapsulated clodronate (Lip-CL) directly after slice culture preparation resulted in specific depletion
of microglia (D), while astrocytes (E) and neurons (F) remained unaffected. After 6 days in culture, the microglia population in Lip-CL treated
slice cultures was reduced to less than 5% (D). Scale bars indicate 300 μM (overviews) and 25 μM (inserts). Confocal images were grey-scaled. (G)
qPCR analysis of control- and Lip-CL-treated slice cultures revealed no differences in the levels of b-III-tubulin and GFAP confirming our
observation that Lip-CL does not affect the presence of neurons and astrocytes. In comparison, CD11b mRNA levels were strongly reduced in
Lip-CL-treated slice cultures, indicating that the number of endogenous microglia left in these slice cultures is really low. Finally, no differences
were observed in NR1, NR2A and NR2B subunit mRNA levels, showing that these were not affected by the Lip-CL treatment. Bars indicate mean
± SEM. ***p < 0.001.
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Page 7 of 15Figure 4 Depletion of microglia with Lip-CL leads to severely enhanced loss of neurons in response to excitotoxicity. Graphs represent
the percentages of neuronal cell death per hippocampal region (A to C) in response to 0, 10, 15, 25 and 50 μM NMDA in untreated (WT
control) and microglia-depleted slice cultures (WT Lip-CL). Microglial depletion alone did not lead to a significant increase in neuronal cell death
(A-C; CNTR). However, in the absence of microglia, neuronal cell death in response to NMDA-induced excitotoxicity was severely enhanced in
the DG (A) and CA3 (B). Confocal images clearly show the effect of microglial depletion on neuronal degeneration in response to 15 μM NMDA
(D-K). Here, in the absence of microglia, neuronal cell death was significantly enhanced in the DG from 12.7% to 66.0% (F,G) and in the CA3
from 41.7% to 94.0% (H, I). In the CA1 (J,K) no significant effect in response to 15 μM NMDA was observed between control and Lip-CL treated
slice cultures (97.1% versus 99.8%, respectively). Data are a summary of three individual experiments with at least 6 slice cultures per condition.
Bars indicate mean ± SEM. **p < 0.01, ***p < 0.001, ANOVA. Scale bars indicate 300 μM( D,E) and 75 μM( F-K).
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41.7 ± 11.3% in controls). At concentrations of 25 μM
and 50 μM NMDA differences in neuronal cell death
were minimal and reached maximum levels under both
conditions (99.6 ± 0.3% and 100% compared to 79.9 ±
8.6% and 96.4 ± 1.5% respectively in controls). In the
CA1 region, no significant differences in neuronal cell
death were observed between control and microglia-
depleted slice cultures as treatment with 10 μM NMDA
already resulted in severe neuronal cell death in both
conditions (Figure 4C, 95.2 ± 1.4% compared to 67.1 ±
16.3% in controls). Treatment of microglia-free slice cul-
tures with NMDA concentrations lower than 10 μM did
not induce neuronal cell death in any of the three hip-
pocampal regions (data not shown).
To ensure that the increase in neuronal vulnerability
is due to the absence of microglia and not to a possible
toxic effect of the Lip-CL treatment, we performed simi-
lar experiments in slice cultures derived from CD11b-
HSVTK (TK) mice. This mouse strain expresses the
herpes simplex virus thymidine kinase (HSV-TK) under
control of the CD11b promoter [25]. Consequently, TK
is only expressed in cells of monocytic lineage, including
microglia. Treatment with the antiviral compound gan-
ciclovir (GCV) leads to microglia paralysis and subse-
quent specific depletion of these cells in the slice
cultures. Here, slice cultures derived from TK and wild
type mice were treated with GCV for the duration of
the experiment, which resulted in specific ablation of
microglia solely in slice cultures derived from TK mice
(Figure 5E) but not in wild type slice cultures (Figure
5D). Similarly to the Lip-CL experiments, depletion of
microglia by GCV treatment did not induce neuronal
cell death in control conditions (Figure 5A-C). However,
when treated with either 10 μMo r1 5μMN M D A ,a
significant increase in neuronal cell death was observed
in microglia-depleted slice cultures compared to wild
type controls, especially in the CA3 and DG regions
(Figure 5B-C). More precisely, in the CA3 region, treat-
ment with 10 μM NMDA resulted in 41.5 ± 10.5% neu-
ronal cell death in microglia-depleted slice cultures
(compared to 6.6 ± 1.7% in controls) while exposure to
15 μM NMDA resulted in 90.3 ± 1.8% neuronal death
in TK slice cultures compared to 56.6 ± 7.2% in wild
type slice cultures. Also in the DG region NMDA-
induced cell death was greatly enhanced in the absence
of microglia as 51.4 ± 15.7% of the neurons died in
response to 10 μM NMDA compared to 4.4 ± 1.1% in
slice cultures derived from wild types. Similarly, treat-
ment with 15 μM NMDA induced significantly more
neuronal cell death in the DG region of GCV-treated
slice cultures derived from TK mice compared to GCV-
treated wild type controls (79.2 ± 11% and 19.5 ± 2.2%,
respectively). In parallel, excitotoxicity experiments were
also performed in slice cultures derived from wild type
and TK mice, which were not treated with GCV. In all
conditions (0, 10 and 15 μM NMDA) neuronal cell
death was comparable with that observed in GCV-trea-
ted slice cultures derived from wild type mice, showing
that GCV treatment per se is not neurotoxic (data not
shown).
Microglia replenishment rescues neurons from
excitotoxicity
Next, we tested whether microglia-depleted slice cul-
tures can be replenished with primary mouse microglia
and subsequently we examined the impact of this
replenishment on neuronal excitotoxicity. Microglia
obtained from primary mixed glia cultures were added
onto depleted slice cultures. After 12 days in culture,
the exogenously applied microglia had invaded the slice
cultures as determined by Iba1 positive immunoreactiv-
ity (Figure 6A). These replenished cells showed a regular
distribution and had acquired a ramified morphology
(Figure 6A). Z-stack analysis revealed that the replen-
ished microglia population integrated into the tissue and
was found in different depths throughout the tissue
( F i g u r e6 B ) .3 Dr e c o n s t r u c tions of both endogenous
microglia (Figure 6C) and replenished primary microglia
(Figure 6D) showed that the replenished cells where
slightly smaller than the endogenous microglia, but
nevertheless showed the typical ramified morphology of
microglia in the non-injured brain (Figure 6C). This dif-
ference in size of the cells was reflected by significantly
shorter process length (Figure 6E) and less branching
points (Figure 6F). Differences in other parameters of
the two cell populations, like cell body size or process
diameter were not observed.
After long-term culturing (21 days in vitro)n e u r o n a l
death was not prominent when microglia where present
in the slice. However, neuronal cell death was evident in
microglia-depleted slice cultures death in control condi-
tions, as measured by the total PI uptake in the DG
region (Figure 6G, 7.9 ± 2.5%). Replenishment with pri-
mary mouse microglia slightly decreased the neuronal
cell death (Figure 6G, 3.5 ± 1.5%), already indicating
that microglia replenishment was beneficial for neuronal
survival.
To test the effects of microglia replenishment on neu-
ronal excitotoxicity, depleted and replenished slice cul-
tures were treated with 25 μM NMDA and neuronal
cell death in the DG region was determined. We
focussed on these conditions since neuronal death in
the DG without microglia is substantial and therefore
ideal to analyse the potential importance of microglia
replenishment. Subjecting 21 days old depleted-slice cul-
tures to 25 μM NMDA resulted in pronounced neuronal
cell death in the DG region, as measured by a total PI
Vinet et al. Journal of Neuroinflammation 2012, 9:27
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Page 9 of 15Figure 5 Microglial depletion in CD11b-HSVTK slice cultures by ganciclovir treatment also results in a strong increase in neuronal cell
death in response to excitotoxicity. Graphs represent the percentages of neuronal cell death per hippocampal region (A to C) in response to
0, 10, and 15 μM NMDA in wild type (TK- GCV+) and microglia-depleted CD11b-HSVTK slice cultures (TK + GCV+). Microglial depletion alone did
not lead to a significant increase in neuronal cell death (A-C; CNTR). However, in the absence of microglia, neuronal cell death in response to
NMDA-induced excitotoxicity was severely enhanced in the DG (A) and CA3 (B). Almost no microglia cells were present when TK slices were
treated with GCV (E) compared to wild type slice cultures (D). Confocal images clearly show the effect of microglial depletion on neuronal
degeneration in response to 15 μM NMDA (F-K). Here, in the absence of microglia, neuronal cell death was significantly increased in the DG
from 19.5% to 79.2% (F,G) and in the CA3 from 56.6% to 90.3% (H, I). In the CA1 (J,K) no significant effect in response to 15 μM NMDA was
observed between wild type and TK slice cultures (96.2% versus 96.6%, respectively). Data are a summary of three individual experiments with at
least 6 slice cultures per condition. Bars indicate mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA. Scale bars indicate 300 μM( D,E) and
75 μM( F-K).
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Page 10 of 15uptake of 53.6 ± 3.2%. Under the same conditions, a sig-
nificantly reduced neuronal death (21.6 ± 2.2%) was
found after replenishment of slice cultures with primary
mouse microglia (Figure 6G).
Discussion
Selective hippocampal neuronal vulnerability in
excitotoxicity: Involvement of microglia
Here, we observed that neurons from the hippocampal
CA1, CA3 and DG regions showed distinct and selective
neuronal vulnerability towards NMDA-induced excito-
toxicity with CA1 neurons being most susceptible to
NMDA followed by CA3 and DG neurons, respectively.
Similar patterns towards excitotoxicity or (hypoxic-)
ischemic insults in the hippocampus have been observed
previously both in vivo [34-38] and in vitro in organoty-
pic slice cultures [32,39-44], corroborating our findings.
Interestingly, selectivity towards NMDA has been shown
to be independent of an intact hippocampal neuronal
circuitry as isolated CA3, CA1 and DG slice cultures
still respond with a selective vulnerability towards
NMDA, with the CA1 and CA3 regions being more sus-
ceptible to NMDA than the DG region [45]. The rea-
sons for these distinct regional differences in neuronal
vulnerability, however, are not well understood. It has
been shown that CA1 neurons express relatively high
levels of AMPA- and NMDA-receptor (-subtypes), while
neurons in the CA3 region express relatively high levels
of kainate-receptors [46,47]. Accordingly, it has been
demonstrated that CA1 neurons are most vulnerable to
glutamate- and NMDA-induced insults, whereas CA3
(and DG) neurons are most sensitive to the excitotoxin
kainic acid [32,37,43,48]. Thus, variability in glutamate
receptor (-subtype) expression and/or endogenous prop-
erties of the distinct neuronal populations in the CA1,
CA3 and DG regions [41,49-51] could (in part) explain
their selective vulnerability towards excitotoxicity.
Here, we provide evidence that selective vulnerability
is not solely based on endogenous neuronal properties.
The differences in neuronal sensitivity to NMDA
Figure 6 Replenishment of microglia-depleted slice cultures with primary mouse microglia reduces excitotoxicity-induced neuronal
cell death. After 9 days in vitro, cultured primary mouse microglia were carefully pipetted onto depleted slice cultures at a density of 400 cells
per slice culture. 12 days later, slice cultures were immuno-stained for NeuN (grey) and Iba1 (yellow) revealing that exogenously applied
microglia showed equal distribution and a ramified morphology (A,D) and were integrated into the tissue (B). The cells (yellow arrows) had
distributed themselves throughout the total depth of the slice cultures as examined by confocal microscopy (B: orthoview of a z-stack). 3D
reconstructions of microglia filaments, created by IMARIS filament tracer software from Iba1 fluorescently stained cells in z-stacks of slice cultures,
were used to analyse the morphology of endogenous microglia and replenished primary mouse microglia. Figure C and D show examples for
reconstructions of endogenous microglia (endo microglia) and replenished primary microglia (primary microglia), respectively. The starting point
of the filaments was set at the cell soma (blue). Analysis of the morphologic parameters total dendritic length (E) and number of branch points
(F) revealed significantly shorter dendritic length and less branching points in replenished primary microglia compared to endogenous microglia
(*** p < 0.001). NMDA (25 μM)-induced neuronal cell death in the dentate gyrus was significantly reduced in slice cultures replenished with
primary mouse microglia (21.6%) compared to microglia-free slice cultures (53.6%), as determined by total PI uptake (G). Data are provided as
mean ± SEM. N = 25 cells per group for E and F and N = 4 for G. Scale bars: Scale bars indicate 100 μm( A-B; shown in A) and 10 μm( C-D).
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Page 11 of 15between the three hippocampal regions disappeared in
the absence of microglia. Without microglia, neurons
from both the CA3 and CA1 region were equally
affected upon treatment with 15-25 μMN M D Aa n d
treatment of microglia-free slice cultures with 50 μM
NMDA even fully abrogated the selective vulnerability
as all three hippocampal regions (CA1, CA3 and DG)
were equally affected in terms of neuronal cell death.
Since the depletion of microglia was achieved under two
different conditions (clodronate treatment in C57BL/6 J
slice cultures and ganciclovir application in CD11b-
HSVTK slice cultures), we assume that our results are
not due to a potential influence of the microglia deple-
tion technique itself. Moreover, we did not find mor-
phological differences in neurons and astrocytes or
changes in NMDA receptor subunit mRNA expression
nor did we observe differences in MK-801 effects when
comparing slice cultures with and without endogenous
microglia. Clodronate liposomes are used to target the
myeloid cell compartment in brain tissue (in slices or in
vivo) for more than 20 years; however, a direct effect in
neurons has never been described. The CD11b-HSVTK
mouse is now used to target microglia for several years.
Although there are fewer publications compared to clo-
dronate, so far no direct effect of ganciclovir treatment
on neurons has been found. Even when ganciclovir was
administered in vivo intraventrically for up to 2 weeks,
no signs of neuronal death were observed as we and
others showed [48,52]. Thus, not the ablation technique
but the absence of microglia enhanced the neuronal
sensitivity, which is in agreement with earlier findings
by us and others [13,14,33,53-55].
We provide here the first evidence that replenishment
of microglia-free slice cultures with cultured primary
microglia is possible. In a surprisingly straight forward
manner, added microglia invade the slice cultures
throughout the hippocampal layers, acquire a regular
distribution and regain a ramified morphology, which is
very similar to endogenous microglia in non-depleted
slice cultures. Several important clues/conclusions can
be drawn from these observations: 1- The fact that the
introduced primary microglia infiltrate the depleted-slice
cultures and ramify argues for non-pathological “tissue
homeostasis” of these slice cultures. Microglia are active
sensors for cellular stress and it is anticipated that their
ramification would not have occurred in the presence of
damaged or stressed cells. 2- Our findings show that
primary microglia, despite the well-known fact that
these cells have a high activation status due to culture
conditions, keep their capacity to acquire a ramified
morphology when brought into a homeostatic neural
environment. It is interesting to note here that microglia
cell lines, such as BV-2 cells, do not show this behavior.
Instead, microglia cell lines remained at the surface of
the slice cultures and proliferated until the entire sur-
face of the slices is covered (data not shown); 3- Most
importantly, the replenishment with ramified microglia
restored the original region specific neuronal sensitivity
towards NMDA-induced neurotoxicity indicating that
microglia not only acquire a ramified morphology, but
also regain their protective function.
These results put a question mark behind numerous
studies describing prominent neurotoxic properties of
cultured microglia. Clearly, cultured microglia have the
ability to damage neurons. However, this prominent
neurotoxic phenotype of cultured shake off microglia
may rather reflect their special activation status in vitro.
Ramified microglia are not “resting” but protective upon
excitotoxicity
Morphological activation of microglia was restricted to
sites of neuronal cell death in our slice culture model
and thus strictly coincided with the selective neuronal
vulnerability to the NMDA-challenge. This morphologi-
cal activation, induced by neuronal stress or cell death
signals, is a well-known feature of microglia that has
already been reported for by del Rio-Hortega about a
century ago [56] and ever since numerous times both in
vivo [36] and in vitro in slice cultures [57]. At 10 μM
NMDA we did not find neuronal loss in the CA3 and
DG regions and therefore no morphological microglia
activation was observed in these regions. From the clas-
sical point of view (looking at morphology only), one
could assume that microglia are not active here. How-
ever, neuronal loss was profound in these regions in the
absence of microglia, clearly indicating that also ramified
(morphologically non-activated) microglia have the
capacity to support neurons during an insult. Moreover,
these findings suggest that a morphological activation of
microglia is not a prerequisite for their neuroprotective
function. It is now clear that ramified microglia in vivo
continuously scan their environment for homeostatic
irregularities [6-8]. The data presented here show that
ramified microglia contribute to the protection of neu-
r o n sa n dt h a ti nc o n c l u s i o n ,o n es h o u l dn o tr e g a r d
ramified microglia as solely monitoring cells, but as a
crucial component that protects neurons from
excitotoxicity.
How microglia exert their neuroprotective function
remains an open question. Recent studies have uncov-
ered potential mechanisms with which microglia could
protect neurons under excitotoxicity. For instance, it
was shown that CXC3CL1 expression on neurons leads
to secretion of adenosine by microglia, which in turn
leads to neuronal increase of adenosine A1 receptors
and neuroprotection [58]. Exposure of hippocampal
slice cultures to GDNF has been shown to activate
microglia, leading to increased neuronal survival [59].
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noid receptor 2 activation in microglia in neuroprotec-
tion against excitotoxicity in Huntington’sd i s e a s e[ 6 0 ] .
Moreover, microglia in the hippocampus of rats sub-
jected to stroke were found to specifically express neu-
roprotective TNFa [61]. Furthermore, it was recently
described that an intravenous injection of the human
microglial cell line HMO6 in ischemic rats leads to
reduced infarct size and improved behavioral outcome,
suggesting a neuroprotective function of these cells by
the upregulation of several inflammatory mediators and
neurotrophic factors [62]. In line with these results, it
has been shown that application of the microglia cell
line BV-2 to slice cultures reduced oxygen-glucose
deprivation-induced neuronal damage [63]. These stu-
dies, however, related protective function to morpholo-
gically activated microglia that improved an ongoing
pathology. We show here that in the absence of ramified
microglia, brain areas (DG, CA3) are affected by a given
insult (NMDA) that would not be damaged in the pre-
sence of these cells. Thus, only the ablation and replen-
ishment of ramified microglia as demonstrated in the
present study unraveled their protective function.
The CD11b-HSVTK model specifically ablates microglia
that undergo activation or proliferation [25], which is why
this model is ideal to deplete microglia in slice cultures.
Moreover this model has been used in vivo in several pub-
lications. Depletion of microglia in vivo in CD11b-HSVTK
mice leads to reduced stroke size [14] or reduced inflam-
mation-dependent pre-conditioning in pilocarpine-
induced seizure activity [48]. Thus, in some instances the
lack of microglia appears to be beneficial. However, neuro-
nal death in response to pilocarpine was not assessed in
the latter report. In two mouse models of Alzheimer’sd i s -
ease (AD) no change in amyloid-beta plaque load was
seen in the absence of microglia [52]. Although the avail-
able AD mice do not provide an ideal model for neurode-
generation, these data argue against substantial microglia-
driven neuritic damage in AD, as amyloid-beta-driven
neural dystrophy appeared to be unaltered in the absence
of microglia in the AD mouse models [52].
In kainate-induced neurotoxicity it recently was found
that the ablation of morphologically activated microglia
was correlated to reduced neuronal loss, showing that
morphologically activated microglia can also promote
the death of neurons [48].
However, none of the reports mentioned above con-
tradicts or supports the findings reported in this study,
since a reliable way to deplete and to replenish ramified
microglia in vivo has yet not been identified. Thus,
although slice cultures are a well accepted model as
they represent many in vivo properties, the question
whether ramified microglia have a protective function in
excitotoxicity also in vivo remains unanswered.
At the moment it is not yet understood how ramified
microglia offer protection against NMDA-induced exci-
totoxicity. Since we did not find significant migration of
microglia between the different neuronal regions (CA1,
CA3 and DG) in response to NMDA-induced excito-
toxicity (data not shown), a local communication
between NMDA-treated neurons and surrounding
microglia can be envisaged. It was recently described
that amoeboid microglia in the developing white matter
of rats express functional NMDA receptors [64]. Our
data, however, do not support an expression of NMDA
receptors in ramified microglia, since depletion of
microglia did not change the NMDA receptor expres-
sion and function in the slice cultures. Moreover, we
just published a mRNA expression analysis of ramified
white matter microglia from the adult mouse and did
not find significant expression of NMDA receptor
mRNA in these cells [65]. It therefore is suggested that
the NMDA-receptor expressing amoeboid microglia in
the developing white matter recently described by Mur-
ugan and colleagues [64] is a specialized phenotype of
microglia and these data add up to the concept that
there are subtypes of microglia cells with different func-
tions [66].
Although insensitive to NMDA, microglia most likely
respond to NMDA-challenged neurons given the
numerous signals that are released from these cells [67].
Whether or not ramified microglia in response release
some of their neurotrophic factors [68,69] should, how-
ever, be further investigated.
Conclusion
Here, we show that depletion of microglia from hippo-
campal slice cultures and subsequent exposure to
NMDA, results in severely enhanced neuronal cell death
compared to slice cultures containing endogenous
microglia. This is further confirmed by replenishment
experiments where cultured microglia added to depleted
slice cultures restored the original resistance of neurons
against NMDA toxicity. These data indicate that rami-
fied microglia not only screen their microenvironment
but additionally protect hippocampal neurons under
pathological conditions.
Additional material
Additional file 1: Figure S1. Effect of MK-801 treatment on NMDA-
induced neuronal loss in mouse hippocampal slice cultures in the
presence and absence of microglia. Hippocampal slice cultures were
treated with concentrations of 0 (control), 10, 15, 25 and 50 μM NMDA.
Treatment with NMDA clearly induced cell death in the slice cultures as
determined by propidium iodide uptake. Treatment of slice cultures with
the NMDA-antagonist MK-801 (30 μM) for one hour prior to NMDA-
treatment completely blocked NMDA-induced neuronal cell death
irrespective of the presence of microglia (Compare panel A with
microglia and panel B without microglia). Data are a summary of two
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Page 13 of 15individual experiments with at least 6 slice cultures per condition. Bars
indicate mean ± SEM.
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